Inventor
Yuan-Tsong Chen
Inventor
Taipei, TW
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
A61KPreparations for medical, dental or toiletry purposes18%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%
C12YEnzymes12%
C12NMicroorganisms or enzymes9%
C07KPeptides8%
Y10TTechnical subjects covered by former us classification3%
PatentTitleYear
10,792,341Treatment of glycogen storage disease type II202010,647,969Method of treating glycogen storage disease type IX using acid alpha-glucosidase20209,907,839'Treatment of glycogen storage disease type II'20189,850,474Methods for treating glycogen storage disease type IV usng lysosomal acid alpha-glucosidase20179,797,015'Genetic variants associated with lithium response in bipolar disorder'20179,562,268'Risk assessment for adverse drug reactions'20179,428,575'Anti-granulysin antibodies and methods of use thereof'20169,370,556'Treatment of glycogen storage disease type II'20169,050,333'Method of treating glycogen storage disease type III with human acid α-glucosidase'20158,927,462'Method for identifying HLA complexes associated with adverse drug reactions'20158,900,552'Treatment of glycogen storage disease type II'20148,377,436'Granulysin and uses thereof'20138,142,999'HLA alleles associated with adverse drug reactions and methods for detecting such'20128,012,686'Risk assessment for adverse drug reactions'20117,964,351'Risk assessment for adverse drug reactions'20117,943,309'HLA alleles associated with adverse drug reactions and methods for detecting such'20117,718,378'Granulysin and uses thereof'20107,666,405'Deleted adenovirus vectors and methods of making and administering the same'20107,470,513'Risk assessment for adverse drug reactions'20087,355,023'Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same'20087,056,712'Treatment of glycogen storage disease type II'20066,797,265'Deleted adenovirus vectors and methods of making and administering the same'20046,328,958'Deleted adenovirus vectors and methods of making and administering the same'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2020Patents assigned to UNIV DUKE (12)· patent assignee history
2001–2020Based in Chapel Hill, NC, US· patent location history
2008–2017Patents assigned to ACADEMIA SINICA (11)· patent assignee history
2008–2017Based in Taipei, TW· patent location history
2011–2012Patents assigned to PHARMIGENE INC (2)· patent assignee history
2012–2015Patents assigned to CHEN YUAN-TSONG (5)· patent assignee history
2012–2015Patents assigned to HUNG SHUEN-IU (3)· patent assignee history
2015–2020Based in Durham, NC, US· patent location history
2016Based in New Taipei, TW· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV DUKE | 12 | 2001–2020 |
| ACADEMIA SINICA | 11 | 2008–2017 |
| CHEN YUAN-TSONGself | 5 | 2012–2015 |
| HUNG SHUEN-IU | 3 | 2012–2015 |
| PHARMIGENE INC | 2 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Taipei, TW | 10 | 2008–2017 |
| Chapel Hill, NC, US | 9 | 2001–2020 |
| Durham, NC, US | 3 | 2015–2020 |
| New Taipei, TW | 1 | 2016 |